Raphael J. Leo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raphael J. Leo has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Rahat Whig
2 shared publicationsAlia N. Syed
Department of Psychiatry, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York
1 shared publicationByung San Kwak
Department of Psychiatry, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA
1 shared publicationDaniel Baer
1 shared publicationDavid A. Chrostowski
1 shared publicationJaime E. Mash
Department of Psychiatry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA
1 shared publication
Latest Publications
- 19 March 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (2)
Recreational Ketamine-Induced Uropathy
- 19 March 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (2)
Recreational Ketamine-Induced Uropathy
- 11 July 2024
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 26 (4) , 55962
Clozapine-Related Cecal Volvulus
This case of clozapine-related cecal volvulus illustrates the need for a high index of suspicion for potentially life-threatening surgical emergencies in clozapine-treated patients.
- 11 July 2024
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 26 (4) , 55962
Clozapine-Related Cecal Volvulus
This case of clozapine-related cecal volvulus illustrates the need for a high index of suspicion for potentially life-threatening surgical emergencies in clozapine-treated patients.
- 1 March 2023
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 53 (3) , 145-148
Onychophagia Progressing to Extensive Finger Amputation: A Brief Review Addressing Severe Body-Focused Repetitive Behavior Disorder in an Adult
- 1 March 2023
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 53 (3) , 145-148
Onychophagia Progressing to Extensive Finger Amputation: A Brief Review Addressing Severe Body-Focused Repetitive Behavior Disorder in an Adult
- 22 November 2022
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 24 (6) , 44189
Recreational 2-Methyl-2-Butanol Use
This report describes a patient whose use of 2-methyl-2-butanol—an inexpensive, easily accessible, potent, and nondetectable ethanol substitute—led to protracted intoxication and delirium.
- 22 November 2022
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 24 (6) , 44189
Recreational 2-Methyl-2-Butanol Use
This report describes a patient whose use of 2-methyl-2-butanol—an inexpensive, easily accessible, potent, and nondetectable ethanol substitute—led to protracted intoxication and delirium.
- 17 March 2022
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 24 (2) , 40184
Mania Associated With Rhodiola Rosea
- 17 March 2022
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 24 (2) , 40184
Mania Associated With Rhodiola Rosea
- 13 August 2020
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 22 (4)
Phenibut
- 13 August 2020
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 22 (4)
Phenibut
- 20 December 2018
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 20 (6)
Oxcarbazepine-Induced Stevens-Johnson Syndrome
From the Primary Care Companion for CNS Disorders:
- 20 December 2018
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 20 (6)
Oxcarbazepine-Induced Stevens-Johnson Syndrome
From the Primary Care Companion for CNS Disorders:
- 19 July 2018
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 20 (4)
Tianeptine Sodium
- 19 July 2018
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 20 (4)
Tianeptine Sodium
- 1 April 2016
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 11 (1) , 136-145
Migraine headache and bipolar disorder comorbidity: A systematic review of the literature and clinical implications
Background and aims: Psychiatric disorders, e.g., depression, are often comorbid with, and can complicate the treatment of, patients with migraine headache. Although empirical work has increasingly focused on the association between migraine and bipolar disorder, this topic has received little attention in the pain literature. Bipolar disorder is a chronic and recurrent mood disorder characterized by cyclic occurrence of elevated (i.e., manic or hypomanic) and depressed mood states. Bipolar I disorder is diagnosed when patients present with at least one abnormally and persistently elevated manic episode; bipolar II disorder is characterized by the presence of hypomanic episodes. Bipolar disorder warrants attention as depressive phases of the disorder can prevail and are often misconstrued by the unwary clinician as unipolar depression. However, treatment for bipolar disorder is distinct from that of unipolar depression and use of antidepressants, which are often invoked in migraine prophylaxis as well as the treatment of depression, may precipitate significant mood changes among bipolar disorder patients. A systematic review of the literature addressing the co-occurrence of bipolar disorder and migraine was conducted. The treatment of dually affected patients is also discussed. Methods: In order to review the literature to date on migraine and bipolar disorder co-occurrence, a comprehensive search of MEDLINE, EMBASE, PubMed, PsycINFO, Web of Science, and CINAHL for clinic-based and epidemiological studies was conducted using terms related to migraine and bipolar disorder . Studies were selected for review if they included subjects meeting validated diagnostic criteria for bipolar disorder as well as migraine headache and if a quantitative description of prevalence rates of comorbid bipolar disorder and migraine were reported. Weighted means of the prevalence rates were calculated to compare with general epidemiological prevalence trends for migraine and bipolar disorder, respectively. Results: Eleven studies met inclusion criteria. Although findings were constrained by methodological limitations and several low quality studies, clinic- and epidemiological cross-sectional investigations demonstrated a high rate of comorbidity between bipolar disorder and migraine. The weighted mean prevalence rate for migraine headache among bipolar disorder patients was 30.7%; for bipolar disorder among migraineurs, the weighted mean prevalence rates were 9% and 5.9% in clinic-based and epidemiological studies, respectively. The association between bipolar disorder and migraine was most notable among women and patients with the bipolar II disorder subtype. Conclusions: High rates of comorbidity exist between migraine and bipolar disorder, exceeding estimated prevalence rates for those conditions in the general population. Comorbidity may portend a more serious clinical course for dually afflicted individuals. Implications: Clinicians need to structure treatment approaches to address concurrent migraine and bipolar disorder in dually afflicted individuals. Although further evidence-based investigation is warranted to inform optimal treatment approaches for both conditions concurrently, anticonvulsants (e.g., valproate, lamotrigine and topiramate); atypical antipsychotics (e.g., olanzapine or quetiapine); and calcium channel blockers (e.g., verapamil) may be considered.
- 1 April 2016
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 11 (1) , 136-145
Migraine headache and bipolar disorder comorbidity: A systematic review of the literature and clinical implications
Background and aims: Psychiatric disorders, e.g., depression, are often comorbid with, and can complicate the treatment of, patients with migraine headache. Although empirical work has increasingly focused on the association between migraine and bipolar disorder, this topic has received little attention in the pain literature. Bipolar disorder is a chronic and recurrent mood disorder characterized by cyclic occurrence of elevated (i.e., manic or hypomanic) and depressed mood states. Bipolar I disorder is diagnosed when patients present with at least one abnormally and persistently elevated manic episode; bipolar II disorder is characterized by the presence of hypomanic episodes. Bipolar disorder warrants attention as depressive phases of the disorder can prevail and are often misconstrued by the unwary clinician as unipolar depression. However, treatment for bipolar disorder is distinct from that of unipolar depression and use of antidepressants, which are often invoked in migraine prophylaxis as well as the treatment of depression, may precipitate significant mood changes among bipolar disorder patients. A systematic review of the literature addressing the co-occurrence of bipolar disorder and migraine was conducted. The treatment of dually affected patients is also discussed. Methods: In order to review the literature to date on migraine and bipolar disorder co-occurrence, a comprehensive search of MEDLINE, EMBASE, PubMed, PsycINFO, Web of Science, and CINAHL for clinic-based and epidemiological studies was conducted using terms related to migraine and bipolar disorder . Studies were selected for review if they included subjects meeting validated diagnostic criteria for bipolar disorder as well as migraine headache and if a quantitative description of prevalence rates of comorbid bipolar disorder and migraine were reported. Weighted means of the prevalence rates were calculated to compare with general epidemiological prevalence trends for migraine and bipolar disorder, respectively. Results: Eleven studies met inclusion criteria. Although findings were constrained by methodological limitations and several low quality studies, clinic- and epidemiological cross-sectional investigations demonstrated a high rate of comorbidity between bipolar disorder and migraine. The weighted mean prevalence rate for migraine headache among bipolar disorder patients was 30.7%; for bipolar disorder among migraineurs, the weighted mean prevalence rates were 9% and 5.9% in clinic-based and epidemiological studies, respectively. The association between bipolar disorder and migraine was most notable among women and patients with the bipolar II disorder subtype. Conclusions: High rates of comorbidity exist between migraine and bipolar disorder, exceeding estimated prevalence rates for those conditions in the general population. Comorbidity may portend a more serious clinical course for dually afflicted individuals. Implications: Clinicians need to structure treatment approaches to address concurrent migraine and bipolar disorder in dually afflicted individuals. Although further evidence-based investigation is warranted to inform optimal treatment approaches for both conditions concurrently, anticonvulsants (e.g., valproate, lamotrigine and topiramate); atypical antipsychotics (e.g., olanzapine or quetiapine); and calcium channel blockers (e.g., verapamil) may be considered.
- 27 January 2016
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 77 (01) , 67-68
A Case of Olfactory Groove Meningioma Misdiagnosed as Schizophrenia
Olfactory groove meningiomas are relatively uncommon slow-growing tumors which can produce symptoms that progress insidiously. Often, patients present with personality changes and cognitive disturbances. These changes may not become apparent until the tumors become quite large, although other factors, eg, peritumoral edema and resultant brain tissue compression, influence clinical presentation.
- 27 January 2016
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 77 (01) , 67-68
A Case of Olfactory Groove Meningioma Misdiagnosed as Schizophrenia
Olfactory groove meningiomas are relatively uncommon slow-growing tumors which can produce symptoms that progress insidiously. Often, patients present with personality changes and cognitive disturbances. These changes may not become apparent until the tumors become quite large, although other factors, eg, peritumoral edema and resultant brain tissue compression, influence clinical presentation.